ZA943246B - Substituted mono- and bipyridylmethylpyridones - Google Patents
Substituted mono- and bipyridylmethylpyridonesInfo
- Publication number
- ZA943246B ZA943246B ZA943246A ZA943246A ZA943246B ZA 943246 B ZA943246 B ZA 943246B ZA 943246 A ZA943246 A ZA 943246A ZA 943246 A ZA943246 A ZA 943246A ZA 943246 B ZA943246 B ZA 943246B
- Authority
- ZA
- South Africa
- Prior art keywords
- bipyridylmethylpyridones
- substituted mono
- mono
- substituted
- reaction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4316077A DE4316077A1 (de) | 1993-05-13 | 1993-05-13 | Substituierte Mono- und Bihydridylmethylpyridone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA943246B true ZA943246B (en) | 1995-01-18 |
Family
ID=6488035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA943246A ZA943246B (en) | 1993-05-13 | 1994-05-11 | Substituted mono- and bipyridylmethylpyridones |
Country Status (21)
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0802192A1 (de) * | 1996-04-17 | 1997-10-22 | Bayer Ag | Heterocyclisch-substituierte Phenylglycinolamide mit antiatherosklerotischer Wirkung und Verfahren zu ihrer Herstellung |
| DE19619950A1 (de) | 1996-04-17 | 1997-10-23 | Bayer Ag | Heterocyclisch-substituierte Phenylglycinolamide |
| US7045519B2 (en) * | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US6417185B1 (en) | 1998-06-19 | 2002-07-09 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| US7998986B2 (en) | 2001-12-21 | 2011-08-16 | Exelixis Patent Company Llc | Modulators of LXR |
| PL218749B1 (pl) * | 2002-02-14 | 2015-01-30 | Pharmacia Corp | Pochodna pirydynonu oraz jej zastosowanie do wytwarzania leku |
| US6930117B2 (en) * | 2002-11-09 | 2005-08-16 | The Procter & Gamble Company | N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones |
| US6946479B2 (en) * | 2002-11-09 | 2005-09-20 | The Procter & Gamble Company | N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones |
| AU2006284900A1 (en) | 2005-08-29 | 2007-03-08 | Vertex Pharmaceuticals Incorporated | 3, 5-disubstituted pyrid-2-ones useful as inhibitors of Tec family of non-receptor tyrosine kinases |
| EP1919905B1 (en) * | 2005-08-29 | 2011-02-23 | Vertex Pharmaceuticals Incorporated | 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-recptor tyrosine kinases |
| WO2007027594A1 (en) * | 2005-08-29 | 2007-03-08 | Vertex Pharmaceuticals Incorporated | 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases |
| AR059898A1 (es) * | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2 |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| TW200845978A (en) * | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| KR101520086B1 (ko) | 2007-09-14 | 2015-05-14 | 얀센 파마슈티칼스 인코포레이티드 | １´,３´-이치환된-４-페닐-３,４,５,６-테트라히드로-２ｈ,１´ｈ-[１,４´]비피리디닐-２´-온 |
| US8252937B2 (en) | 2007-09-14 | 2012-08-28 | Janssen Pharmaceuticals, Inc. | 1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones |
| JP5433579B2 (ja) * | 2007-09-14 | 2014-03-05 | ジャンセン ファーマシューティカルズ， インコーポレイテッド． | １，３−二置換−４−フェニル−１ｈ−ピリジン−２−オン |
| CN101861316B (zh) * | 2007-11-14 | 2013-08-21 | 奥梅-杨森制药有限公司 | 咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途 |
| BRPI0918055A2 (pt) | 2008-09-02 | 2015-12-01 | Addex Pharmaceuticals Sa | derivados de 3-azabiciclo[3,1,0]hexila como moduladores de receptores metabotrópicos de glutamato. |
| AU2009304293B2 (en) | 2008-10-16 | 2012-04-26 | Addex Pharma S.A. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| JP5690277B2 (ja) | 2008-11-28 | 2015-03-25 | ジャンセン ファーマシューティカルズ， インコーポレイテッド． | 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体 |
| JP5707390B2 (ja) | 2009-05-12 | 2015-04-30 | ジャンセン ファーマシューティカルズ， インコーポレイテッド | １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体の正のアロステリック調節因子としてのその使用 |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| PT2430022E (pt) | 2009-05-12 | 2013-12-26 | Janssen Pharmaceuticals Inc | Derivados de 1,2,3-triazolo[4,3-a]piridina e a sua utilização para o tratamento ou prevenção de doenças neurológicas e psiquiátricas |
| JP5599467B2 (ja) | 2009-11-06 | 2014-10-01 | エアーピオ セラピューティクス インコーポレイテッド | プロリルヒドロキシラーゼ阻害剤 |
| WO2012062751A1 (en) | 2010-11-08 | 2012-05-18 | Janssen Pharmaceuticals, Inc. | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
| WO2012062759A1 (en) | 2010-11-08 | 2012-05-18 | Janssen Pharmaceuticals, Inc. | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
| JP5852664B2 (ja) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用 |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| PT3096790T (pt) | 2014-01-21 | 2019-10-15 | Janssen Pharmaceutica Nv | Combinações compreendendo moduladores alostéricos positivos ou agonistas ortostéricos do recetor glutamatérgico metabotrópico do subtipo 2 e seu uso |
| EP3827830A1 (en) | 2014-01-21 | 2021-06-02 | Janssen Pharmaceutica NV | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
| EP4288430A1 (en) | 2021-02-02 | 2023-12-13 | Liminal Biosciences Limited | Gpr84 antagonists and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL100917A0 (en) * | 1991-02-16 | 1992-11-15 | Fisons Plc | Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them |
| US5196537A (en) * | 1991-03-21 | 1993-03-23 | G. D. Searle & Co. | 5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders |
| US5128327A (en) * | 1991-03-25 | 1992-07-07 | Merck & Co., Inc. | Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle |
| US5164403A (en) * | 1991-04-05 | 1992-11-17 | G. D. Searle & Co. | N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders |
| US5155117A (en) * | 1991-04-12 | 1992-10-13 | G. D. Searle & Co. | 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders |
| US5332750A (en) * | 1991-09-04 | 1994-07-26 | Merck Patent Gesellschaft Mit Beschrankter Haftung | 1,2-dihydro-2-oxopyridines |
| DE4129340A1 (de) * | 1991-09-04 | 1993-03-11 | Merck Patent Gmbh | 1,2-dihydro-2-oxopyridine |
| US5149699A (en) * | 1991-10-24 | 1992-09-22 | American Home Products Corporation | Substituted pyridopyrimidines useful as antgiotensin II antagonists |
-
1993
- 1993-05-13 DE DE4316077A patent/DE4316077A1/de not_active Withdrawn
-
1994
- 1994-04-18 TW TW083103408A patent/TW245718B/zh active
- 1994-04-19 AU AU60561/94A patent/AU672679B2/en not_active Ceased
- 1994-05-02 EP EP94106834A patent/EP0624583B1/de not_active Expired - Lifetime
- 1994-05-02 AT AT94106834T patent/ATE155782T1/de active
- 1994-05-02 DK DK94106834.8T patent/DK0624583T3/da active
- 1994-05-02 DE DE59403427T patent/DE59403427D1/de not_active Expired - Fee Related
- 1994-05-02 ES ES94106834T patent/ES2105408T3/es not_active Expired - Lifetime
- 1994-05-06 HU HU9401417A patent/HUT70485A/hu unknown
- 1994-05-06 US US08/239,197 patent/US5407948A/en not_active Expired - Fee Related
- 1994-05-10 FI FI942160A patent/FI942160A7/fi unknown
- 1994-05-10 NZ NZ260490A patent/NZ260490A/en unknown
- 1994-05-10 CA CA002123243A patent/CA2123243A1/en not_active Abandoned
- 1994-05-10 JP JP6120653A patent/JPH06329669A/ja active Pending
- 1994-05-10 IL IL10960494A patent/IL109604A0/xx unknown
- 1994-05-11 NO NO941770A patent/NO941770L/no unknown
- 1994-05-11 PH PH48253A patent/PH30908A/en unknown
- 1994-05-11 ZA ZA943246A patent/ZA943246B/xx unknown
- 1994-05-11 SK SK556-94A patent/SK55694A3/sk unknown
- 1994-05-12 CZ CZ941172A patent/CZ117294A3/cs unknown
- 1994-05-13 CN CN94105814A patent/CN1102648A/zh active Pending
-
1997
- 1997-08-14 GR GR970402103T patent/GR3024465T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9401417D0 (en) | 1994-08-29 |
| SK55694A3 (en) | 1995-02-08 |
| AU6056194A (en) | 1994-11-17 |
| CZ117294A3 (en) | 1994-11-16 |
| AU672679B2 (en) | 1996-10-10 |
| NZ260490A (en) | 1995-12-21 |
| TW245718B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1995-04-21 |
| US5407948A (en) | 1995-04-18 |
| GR3024465T3 (en) | 1997-11-28 |
| NO941770L (no) | 1994-11-14 |
| FI942160L (fi) | 1994-11-14 |
| DE59403427D1 (de) | 1997-08-28 |
| NO941770D0 (no) | 1994-05-11 |
| ATE155782T1 (de) | 1997-08-15 |
| EP0624583A1 (de) | 1994-11-17 |
| FI942160A0 (fi) | 1994-05-10 |
| ES2105408T3 (es) | 1997-10-16 |
| CN1102648A (zh) | 1995-05-17 |
| PH30908A (en) | 1997-12-23 |
| FI942160A7 (fi) | 1994-11-14 |
| EP0624583B1 (de) | 1997-07-23 |
| DE4316077A1 (de) | 1994-11-17 |
| IL109604A0 (en) | 1994-08-26 |
| CA2123243A1 (en) | 1994-11-14 |
| DK0624583T3 (da) | 1998-03-02 |
| JPH06329669A (ja) | 1994-11-29 |
| HUT70485A (en) | 1995-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW245718B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| MY129973A (en) | Sulphonylbenzyl-substituted pyridones. | |
| HUT49791A (en) | Fungicide composition containing quinazoline derivative as active component and process for producing the active component | |
| ZA933273B (en) | Sulfonylbenzyl-substituted benzo- and pyridopyridones | |
| GR3036287T3 (en) | Substituted imidazo(4,5-b)pyridines and benzimidazoles as angiotensin II antagonistes. | |
| AU2861389A (en) | Disubstituted pyridines | |
| HUT47794A (en) | Insecticide, acaricide and nematocide compositions containing pyridazinone derivatives as active components and process for producing the active components | |
| GR3023194T3 (en) | Imidazole substituted phenylaceticacidprolinzamide derivatives. | |
| TW241264B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| AU7037987A (en) | Oxygen generating herbicides synergized with detoxifying enzyme inhibitor | |
| TW245713B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| EP0333020A3 (en) | Process for the preparation of substituted pyridines | |
| NO910163L (no) | Fremgangsmaate for fremstilling og anvendelse av pyridin-2,4- og 2,5-dikarboksylsyredi-(nitroksyalkyl)amid. | |
| AU7719491A (en) | Therapeutic compound | |
| IE890159L (en) | Substituted pyridines |